...open-label, Belgian Phase II trial in 15 CAD patients showed that CardioPET was well tolerated. FluoroPharma...
...were presented at the Society of Nuclear Medicine and Molecular Imaging meeting in Palm Springs. FluoroPharma...

...$0.83 Shares after offering: 18.2 million Placement agents: Burnham Hill Partners; Monarch Capital Group Note: FluoroPharma...

...to form FluoroPharma Medical Inc. (OTCBB:CEWM). Under the deal, FluoroPharma Inc. shareholders received about 13.9 million FluoroPharma...
...warrants to purchase shares of FluoroPharma Medical. The newco will focus on the development of FluoroPharma's...
...that has also completed Phase I testing. Commercial E Waste Management Inc. (OTCBB:CEWM), Scottsdale, Ariz. FluoroPharma Inc....

...emission tomography (PET) imaging. Data were presented at the World Molecular Imaging Congress in Nice. FluoroPharma Inc....

...emission tomography (PET) imaging. Data were presented at the World Molecular Imaging Congress in Nice. FluoroPharma Inc....

...single injections of BFPET were well tolerated and had rapid blood clearance and myocardial uptake. FluoroPharma Inc....